Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn

M Shahgolzari, A Yavari, Y Arjeini, SM Miri, A Darabi… - Gene reports, 2021 - Elsevier
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) directly interacts
with host's epithelial and immune cells, leading to inflammatory response induction, which is …

Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia

L Lin, L Lu, W Cao, T Li - Emerging microbes & infections, 2020 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact …

Symptom burden and immune dynamics 6 to 18 months following mild severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2): a case-control study

EB Fjelltveit, B Blomberg, K Kuwelker… - Clinical Infectious …, 2023 - academic.oup.com
Background The burden and duration of persistent symptoms after nonsevere coronavirus
disease 2019 (COVID-19) remains uncertain. This study aimed to assess postinfection …

Immunogenetic association underlying severe COVID-19

K McCoy, A Peterson, Y Tian, Y Sang - Vaccines, 2020 - mdpi.com
SARS-CoV2 has caused the current pandemic of new coronavirus disease 2019 (COVID-
19) worldwide. Clinical outcomes of COVID-19 illness range broadly from asymptotic and …

Will host genetics affect the response to SARS-CoV-2 vaccines? Historical precedents

MK Smatti, HA Alkhatib, AA Al Thani… - Frontiers in …, 2022 - frontiersin.org
Recent progress in genomics and bioinformatics technologies have allowed for the
emergence of immunogenomics field. This intersection of immunology and genetics has …

[HTML][HTML] Immunology of COVID-19: current state of the science

N Vabret, GJ Britton, C Gruber, S Hegde, J Kim… - Immunity, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …

Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: possible favorable mechanisms of interaction

DE Larenas-Linnemann… - Allergy and Asthma …, 2021 - ingentaconnect.com
Background: Both, allergen immunotherapy (AIT) and SARS-COV-2 infection cause a set of
immunologic changes that respectively vary during the course of the treatment or the …

[HTML][HTML] An impaired inflammatory and innate immune response in COVID-19

SH Park - Molecules and cells, 2021 - Elsevier
The recent appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has affected millions of people around the world and caused a global pandemic of …

A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program

A Verma, NL Tsao, LO Thomann, YL Ho… - PLoS …, 2022 - journals.plos.org
The study aims to determine the shared genetic architecture between COVID-19 severity
with existing medical conditions using electronic health record (EHR) data. We conducted a …

COVID‐19: a series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS‐CoV‐2 infection and care of allergy patients

O Pfaar, MJ Torres, CA Akdis - Allergy, 2021 - Wiley Online Library
Furthermore, a cessation or interruption of allergen immunotherapy (AIT) for both the
subcutaneous route (SCIT) or sublingual route (SLIT) is not recommended in asymptomatic …